Presynaptic membrane receptors at the cholinergic neuromuscular junction

Presynaptic membrane receptors at the cholinergic neuromuscular junction (NMJ) are a heterogeneous group of proteins located on the motor nerve terminal that regulate the release of acetylcholine (ACh) (StatPearls: Physiology, Neuromuscular Junction [1]). These receptors primarily include muscarinic acetylcholine receptors (mAChRs) and nicotinic acetylcholine receptors (nAChRs) that function as autoreceptors to provide feedback control (PubMed: Presynaptic receptors at the neuromuscular junction [2]). Specifically, M1 muscarinic and certain nicotinic subtypes, such as alpha-3-beta-2, facilitate ACh release during high-frequency nerve stimulation to ensure reliable muscle contraction (PubMed: Muscarinic and nicotinic receptors at the NMJ [3]). Conversely, M2 muscarinic receptors provide inhibitory feedback to limit ACh release and prevent synaptic fatigue or overstimulation (UniProt: CHRM2 [4]). These presynaptic mechanisms are critical for maintaining the safety factor of neuromuscular transmission and ensuring efficient motor function. Pathological conditions such as Lambert-Eaton myasthenic syndrome involve presynaptic dysfunction, although primarily through calcium channel antibodies rather than the receptors themselves. Pharmacological agents, including certain neuromuscular blocking drugs like pancuronium, can interact with these presynaptic receptors, potentially influencing the depth and duration of muscle relaxation.

Other names

Presynaptic cholinergic autoreceptorsNMJ presynaptic receptorsMotor nerve terminal receptorsPresynaptic muscarinic and nicotinic receptors

Modulation of acetylcholine release through positive and negative feedback loops at the motor nerve terminal.